CAT No: CP27231
CAS No:57817-43-3
Synonyms/Alias:Biocytin;N'-Biotinyl-L-lysine;576-19-2;Biotinyl-L-lysine;Ne-Biotynyl-L-lysine;N6-D-Biotinyl-L-lysine;N6-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-Lysine;n6-{5-[(3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanoyl}-l-lysine;(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanamido}-2-aminohexanoicacid;(+)-Biocytin;N-biotinyl-L-lysine;H-Lys(biotinyl)-OH;epsilon-N-biotinyllysine;N-epsilon-Biotin-L-lysine;AC1Q6FU7;N6-delta-Biotinyl-L-lysine;N(6)-D-biotinyl-L-lysine;N(epsilon)-biotinyl-L-lysine;B4261_SIGMA;SCHEMBL305707;N|A-(+)-Biotinyl-L-lysine;AC1L368F;UNII-G6D6147J22;C16H28N4O4S;CHEBI:27870
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More